共 98 条
[1]
Enzinger PC(2003)Esophageal cancer N Engl J Med 349 2241-2252
[2]
Mayer RJ(2007)Surgical treatment for esophageal cancer. Current Issues Dig Surg 24 88-95
[3]
Kato H(2017)Prediction of Cancer incidence and mortality in Korea, 2017 Cancer Res Treat 49 306-312
[4]
Fukuchi M(2020)HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population Diagn Pathol 15 27-67
[5]
Miyazaki T(2018)Safety and antitumor activity of the anti-programmed Death-1 antibody Pembrolizumab in patients with advanced esophageal carcinoma J Clin Oncol 36 61-416
[6]
Jung KW(2016)Regulation of PD-L1: a novel role of pro-survival signalling in cancer Ann Oncol 27 409-10567
[7]
Won YJ(2016)Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Oncotarget. 7 10557-923
[8]
Oh CM(2015)Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: implication for optional immune targeted therapy for NSCLC patients with EGFR mutation J Thorac Oncol 10 910-39
[9]
Rong L(2018)Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition Hum Pathol 80 28-82414
[10]
Wang B(2017)Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection Oncotarget. 8 82399-413